bupropion has been researched along with Hepatic Failure in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Understanding the pharmacokinetic (PK) properties and formulations of bupropion can help optimize clinical use." | 2.43 | Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. ( Jefferson, JW; Muir, KT; Pradko, JF, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jefferson, JW | 1 |
| Pradko, JF | 1 |
| Muir, KT | 1 |
1 review available for bupropion and Hepatic Failure
| Article | Year |
|---|---|
Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Area Under Curve; Aryl Hydrocarbon Hydroxy | 2005 |